Browse Title Index

Issue Title
Vol 15, No 2 (2008) Biochemotherapy for the Treatment of Metastatic Malignant Melanoma: A Clinical Practice Guideline Abstract   PDF
Denise Stys-Norman
Vol 23, No 5 (2016) Bioelectrical impedance phase angle as a prognostic indicator of survival in head-and-neck cancer Abstract   PDF   HTML
M.S. Wladysiuk, R. Mlak, K. Morshed, W. Surtel, A. Brzozowska, T. Małecka-Massalska
Vol 21, No 4 (2014) Biologic, psychological, and social health needs in cancer care: how far have we come? Abstract   PDF   HTML
F. Schulte
Vol 13, No 1 (2006) Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma Details   PDF
Lara J Williams, Duane L Guernsey, Alan G Casson
Vol 19 (2012): Personalized Medicine in Metastatic NSCLC: a Canadian Perspective Biomarkers that currently affect clinical practice: EGFR, ALK, MET, KRAS Abstract   PDF   HTML
M.D. Vincent, M.S. Kuruvilla, N.B. Leighl, S. Kamel-Reid
Vol 27, No 1 (2020) Biopsy on progression in patients with EGFR mutation–positive advanced non-small-cell lung cancer—a Canadian experience Abstract   PDF   HTML
Q. Chu, A. Agha, N. Devost, R. N. Walton, S. Ghosh, C. Ho
Vol 16, No 6 (2009) Bogarting that joint might decrease oral HPV among cannabis users Abstract   PDF
S. Zwenger
Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective Bone health in nonmetastatic prostate cancer: what’s the big deal? Abstract   PDF
J.B. Lattouf, F. Saad
Vol 19, No 5 (2012) Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art Abstract   PDF   HTML
M. Clemons, K.A. Gelmon, K.I. Pritchard, A.H.G. Paterson
Vol 17, No 4 (2010) BONUS 5: 5th Annual Bone and The Oncologist New Updates Abstract   PDF
N. Bouganim, E. Amir, M. Clemons
Vol 23, No 5 (2016) Book review: Balanced Ethics Review: A Guide for Institutional Review Board Members Abstract   PDF   HTML
T. Christie
Vol 23, No 1 (2016) Book review: Hypnotic Approaches in Cancer and Palliative Care Abstract   PDF   HTML
G. Giddings
Vol 22, No 3 (2015) Book review: Therapeutic Revolution: The History of Medical Oncology From Early Days to the Creation of the Subspecialty Abstract   PDF   HTML
C.I. Falkson
Vol 22, No 3 (2015) Book review: Therapeutic Revolution: The History of Medical Oncology From Early Days to the Creation of the Subspecialty Abstract   PDF   HTML
G. Giddings
Vol 22, No 3 (2015) Book review: Therapeutic Revolution: The History of Medical Oncology From Early Days to the Creation of the Subspecialty Abstract   PDF   HTML
J. Ragaz, S. Shakeraneh
Vol 13, No 5 (2006) Bortezomib in Multiple Myeloma and Lymphoma: A systematic review and clinical practice guideline Details   PDF
Christopher A Smith
Vol 21, No 4 (2014) Bortezomib in multiple myeloma: systematic review and clinical considerations Abstract   PDF   HTML
T.C. Kouroukis, F.G. Baldassarre, A.E. Haynes, K. Imrie, D.E. Reece, M.C. Cheung
Vol 21, No 6 (2014) BRAF mutation correlates with recurrent papillary thyroid carcinoma in Chinese patients Abstract   PDF   HTML
W.Y. Fang, L. Ye, X.F. Zhang, L.Y. Shen, R.L. Han, Q. Wei, X.C. Fei, X. Chen, W.Q. Wang, S. Wang, G. Ning
Vol 26, No 3 (2019) Brain cancer survival in Canada 1996–2008: effects of sociodemographic characteristics Abstract   PDF   HTML
E. V. Walker, J. Ross, Y. Yuan, T. R. Smith, F. G. Davis
Vol 16, No 1 (2009) Brain Metastases from Unknown Primary or Primary Brain Tumor: A Diagnostic Dilemma Details   PDF
Sarah Campos, Philip Davey, Amanda Hird, Bryn Pressnail, Juan Bilbao, Richard Aviv, Sean Symons, Farhad Pirouzmand, Emily Sinclair, Shaelyn Culleton, Eric deSa, Philiz Goh, Edward Chow
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Brain metastases in non-small-cell lung cancer: are tyrosine kinase inhibitors and checkpoint inhibitors now viable options? Abstract   PDF   HTML
S. Morin-Ben Abdallah, A. Wong
Vol 22, No 4 (2015) BRCA1/2 population screening: embracing the benefits Abstract   PDF   HTML
S.E. Plon
Vol 18, No 1 (2011) Breaking new ground in a new year Details   PDF   HTML
M. McLean
Vol 21, No 5 (2014) Breast and cervical cancer screening behaviours among colorectal cancer survivors in Nova Scotia Abstract   PDF   HTML
M. Corkum, R. Urquhart, G. Kephart, J.A. Hayden, G. Porter
Vol 24, No 5 (2017) Breast cancer and dermatomyositis: a case study and literature review Abstract   PDF   HTML
E. Hendren, O. Vinik, H. Faragalla, R. Haq
Vol 20, No 1 (2013) Breast cancer and the environment: what is left to learn? Details   PDF   HTML
S. Narod
Vol 20, No 5 (2013) Breast cancer and the environment: why research and preventive action are needed Abstract   PDF   HTML
J.T. Brophy, M.M. Keith, R. Park, A. Watterson, M. Gilbertson, R. DeMatteo
Vol 22, No 5 (2015) Breast cancer screening panels continue to confuse the facts and inject their own biases Abstract   PDF   HTML
D.B. Kopans
Vol 26, No 6 (2019) Breast cancer screening policy—good science should trump bad politics Abstract   PDF   HTML
M. J. Yaffe
Vol 20, No 2 (2013) Breast cancer survivorship and South Asian Women: understanding about the follow-up care plan and perspectives and preferences for information post treatment Abstract   PDF   HTML
S. Singh-Carlson, F. Wong, L. Martin, S.K.A. Nguyen
Vol 24, No 3 (2017) Breast magnetic resonance imaging: are those who need it getting it? Abstract   PDF   HTML
S. Tan, J. David, L. Lalonde, M. El Khoury, M. Labelle, R. Younan, E. Patocskai, J. Richard, I. Trop
Vol 26, No 1 (2019) Brigatinib is another treatment option for patients diagnosed with advanced ALK-positive non-small-cell lung cancer who are treatment-naïve or who have progressed on or are intolerant to crizotinib Abstract   PDF   HTML
B. Melosky, P. Cheema, G. Liu
2008: Presentations from the Integrating Wellness into Cancer Care Conference Bringing wellness back into health care: the role of social networks Abstract   PPT Presentation
Alex R. Jadad
Vol 14, No 6 (2007) Broad funding for oxaliplatin in Ontario Details   PDF
Derek J Jonker
Vol 24, No 3 (2017) Budget impact analysis of a breast rapid diagnostic unit Abstract   PDF   HTML
M. Elmi, H. Hussain, S. Nofech-Mozes, B. Curpen, A. Leahey, N. Look Hong
Vol 25, No 6 (2018) Building an oncology community of practice to improve cancer care Abstract   PDF   HTML
W. Fingrut, L. A. Beck, D. Lo
Vol 26, No 1 (2019) Building capacity in cancer knowledge translation through catalyst grants Abstract   PDF   HTML
M. A. O'Brien, E. Grunfeld
Vol 23, No 6 (2016) Burden of illness for metastatic melanoma in Canada, 2011–2013 Abstract   PDF   HTML
D.S. Ernst, T. Petrella, A.M. Joshua, A. Hamou, M. Thabane, S. Vantyghem, F. Gwadry-Sridhar
Vol 23, No 2 (2016) But other than mesothelioma? An estimate of the proportion of work-related cancers in Quebec Abstract   PDF   HTML
F. Labrèche, P. Duguay, A. Boucher, R. Arcand
Vol 27, No 1 (2020) Can concordance between actual care received and a pathway map be measured on a population level in Ontario? A pilot study Abstract   PDF   HTML
K. Forster, K. Tsang, S. Li, L. Ieraci, P. Murray, K. J. Woltman, D. Chmelnitsky, C. M.B. Holloway, E. D. Kennedy
Vol 26 (2019): Advances in Colorectal Cancer: Translating Best Evidence to Practice Can less be more? Organ preservation strategies in the management of rectal cancer Abstract   PDF   HTML
F. Rouleau-Fournier, C. J. Brown
Vol 21, No 2 (2014) Can oncologists predict survival for patients with progressive disease after standard chemotherapies? Abstract   PDF   HTML
T.K. Taniyama, K. Hashimoto, N. Kastumata, A. Hirakawa, K. Yonemori, M. Yunokawa, C. Shimizu, K. Tamura, M. Ando, Y. Fujiwara
Vol 23, No 3 (2016) Can the referring surgeon enhance accrual of breast cancer patients to medical and radiation oncology trials? The ENHANCE study Abstract   PDF   HTML
A. Arnaout, I. Kuchuk, N. Bouganim, G. Pond, S. Verma, R. Segal, S. Dent, S. Gertler, X. Song, F. Kanji, M. Clemons
Vol 22, No 2 (2015) Canadian cancer screening disparities: a recent historical perspective Abstract   PDF   HTML
J. Kerner, J. Liu, K. Wang, S. Fung, C. Landry, G. Lockwood, L. Zitzelsberger, V. Mai
Vol 18, No 5 (2011) Canadian College of Medical Geneticists guidelines for the indications, analysis, and reporting of cancer specimens Abstract   PDF   HTML
A. J. Dawson, J. McGowan-Jordan, J. Chernos, J. Xu, J. Lavoie, J.-C. Wang, M. R. Steinraths, S. Shetty
Vol 22, No 2 (2015) Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxis Abstract   PDF   HTML
J.C. Easaw, M.A. Shea-Budgell, C.M.J. Wu, P.M. Czaykowski, J. Kassis, B. Kuehl, H.J. Lim, M. MacNeil, D. Martinusen, P.A. McFarlane, E. Meek, O. Moodley, S. Shivakumar, V. Tagalakis, S. Welch, P. Kavan
Vol 22, No 2 (2015) Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment Abstract   PDF   HTML
J.C. Easaw, M.A. Shea-Budgell, C.M.J. Wu, P.M. Czaykowski, J. Kassis, B. Kuehl, H.J. Lim, M. MacNeil, D. Martinusen, P.A. McFarlane, E. Meek, O. Moodley, S. Shivakumar, V. Tagalakis, S. Welch, P. Kavan
Vol 23, No 3 (2016) Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancer Abstract   PDF   HTML
B. Melosky, J. Agulnik, R. Albadine, S. Banerji, D.G. Bebb, D. Bethune, N. Blais, C. Butts, P. Cheema, P. Cheung, V. Cohen, J. Deschenes, D.N. Ionescu, R. Juergens, S. Kamel-Reid, S.A. Laurie, G. Liu, W. Morzycki, M.S. Tsao, Z. Xu, V. Hirsh
Vol 26, No 1 (2019) Canadian consensus: oligoprogressive, pseudoprogressive, and oligometastatic non-small-cell lung cancer Abstract   PDF   HTML
S. A. Laurie, S. Banerji, N. Blais, S. Brule, P. K. Cheema, P. Cheung, N. Daaboul, D. Hao, V. Hirsh, R. Juergens, J. Laskin, N. Leighl, R. MacRae, G. Nicholas, D. Roberge, J. Rothenstein, D. J. Stewart, M. S. Tsao
Vol 25, No 5 (2018) Canadian evidence-based guideline for the first-line treatment of chronic lymphocytic leukemia Abstract   PDF   HTML   Supplemental Material
C. Owen, A. S. Gerrie, V. Banerji, S. Assouline, C. Chen, K. S. Robinson, E. Lye, G. Fraser
Vol 18, No 4 (2011) Canadian Expert Group consensus recommendations: KRAS testing in colorectal cancer Abstract   PDF   HTML
F. Aubin, S. Gill, R. Burkes, B. Colwell, S. Kamel–Reid, S. Koski, A. Pollett, B. Samson, M. Tehfe, R. Wong, S. Young, D. Soulieres
Vol 18, No 3 (2011) Canadian initiatives for locally advanced breast cancer research and treatment: inaugural meeting of the Canadian Consortium for LABC Abstract   PDF   HTML
M. Brackstone, A. Robidoux, S. Chia, J. Mackey, R. Dent, J. F. Boileau, M. Clemons
Vol 20, No 4 (2013) Canadian integrative oncology research priorities: results of a consensus-building process Abstract   PDF   HTML
L.C. Weeks, D. Seely, L.G. Balneaves, H.S. Boon, A. Leis, D. Oneschuk, S.M. Sagar, M.J. Verhoef
Vol 24, No 4 (2017) Canadian Lung Cancer Conference 2017 Abstract   PDF   HTML
N. Chooback, B. Melosky, C. Ho
Vol 25, No 3 (2018) Canadian Lung Cancer Conference 2018 Abstract   PDF   HTML
S. Lau, Y. Wang, C. Ho, B. Melosky
Vol 26, No 4 (2019) Canadian Lung Cancer Conference 2019 Abstract   PDF   HTML
A. Pender, E. M. Dunne, S. K. Wong, C. Ho, B. Melosky
Vol 25, No 5 (2018) Canadian perspectives: update on inhibition of ALK-positive tumours in advanced non-small-cell lung cancer Abstract   PDF   HTML
B. Melosky, P. Cheema, J. Agulnik, R. Albadine, D. G. Bebb, N. Blais, R. Burkes, C. Butts, P. B. Card, A.M Y. Chan, V. Hirsh, D. N. Ionescu, R Juergens, W. Morzycki, Z. Poonja, R. Sangha, M. Tehfe, M. S. Tao, M. Vincent, Z. Xu, G. Liu
Vol 23, No 2 (2016) Canadian recommendations for the management of breakthrough cancer pain Abstract   PDF   HTML
P. Daeninck, B. Gagnon, R. Gallagher, J.D. Henderson, Y. Shir, C. Zimmermann, B. Lapointe
Vol 14, No 3 (2007) Canadian Recommendations for the Treatment of Glioblastoma Multiforme Details   PDF
Warren Mason
Vol 18, No 3 (2011) Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme Abstract   PDF   HTML
J. C. Easaw, W. P. Mason, J. Perry, N. Laperrière, D. D. Eisenstat, R. Del Maestro, K. Bélanger, D. Fulton, D. Macdonald
Vol 14, No 5 (2007) Canadian Supportive Care Recommendations for the Management of Anemia in Patients with Cancer Details   PDF
Joseph Mikhael, Barbara Melosky, Christine Cripps, Daniel Rayson, Tom Kouroukis
Vol 15, No 1 (2008) Canadian Supportive Care Recommendations for the Management of Neutropenia in Patients with Cancer Abstract   PDF
C. Tom Kouroukis, Joseph Mikhael, Sunil Verma, Stephen Chia, Christine Desbiens, Danny Robson, Christine Cripps
Vol 20, No 1 (2013) Canadian trends in liver cancer: a brief clinical and epidemiologic overview Abstract   PDF   HTML
P. De, D. Dryer, M.C. Otterstatter, R. Semenciw
Susan Solymoss
Vol 21, No 3 (2014) Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management Abstract   PDF   HTML
E. Donnellan, B. Kevane, B.R. Healey Bird, F. Ni Ainle
Vol 14, No 5 (2007) Cancer Antigen 125 in Ovarian Cancer Surveillance: A Decision Analysis Model Details   PDF
Laura Hopkins, Doug Coyle, Tien Le, Michael Fung Kee Fung, George Wells
Vol 22, No 3 (2015) Cancer care burden: aiming at the Achilles heel Abstract   PDF   HTML
S. Ahmed, R.K. Shahid, K. Gesy
Vol 23, No 6 (2016) Cancer care in South India: perspectives from visiting Canadian oncologists Abstract   PDF   HTML
S. Karim, J.C. Del Paggio, S.R. Berry, C.M. Booth
Vol 19, No 1 (2012) Cancer control: life and death in an unequal world Abstract   PDF   HTML
S. B. Sutcliffe
Vol 16, No 6 (2009) Cancer diagnostic assessment programs: standards for the organization of care in Ontario Abstract   PDF
T. Oliver, M. Brouwers, J. Crawford, P. Ellison, W. Evans, A. Gagliardi, J. Lacourciere, V. Mai, S. McNair, T. Minuk, l. Radeneck, C. Rand, J. Ross, D. Lo, J. Smylie, J. Srigley, H. Stern, M. Trudeau
Vol 23, No 1 (2016) Cancer Evolution–Development: experience of hepatitis B virus–induced hepatocarcinogenesis Abstract   PDF   HTML
W.B. Liu, J.F. Wu, Y. Du, G.W. Cao
Vol 23, No 4 (2016) Cancer incidence, mortality, and stage at diagnosis in First Nations living in Manitoba Abstract   PDF   HTML
K.M. Decker, E.V. Kliewer, A.A. Demers, K. Fradette, N. Biswanger, G. Musto, B. Elias, D. Turner
2008: Presentations from the Integrating Wellness into Cancer Care Conference CANCER IS A WORD NOT A SENTENCE Abstract   PPT Presentation
Robert Buckman
Vol 20, No 2 (2013) Cancer Narratives: Words Beyond Disease A Call for Submissions Details   PDF   HTML
D. Rayson
Vol 15, No 3 (2008) Cancer Nutrition and Rehabilitation – Its Time has Come! Abstract   PDF
Martin R. Chasen
Vol 17, No 6 (2010) Cancer nutrition rehabilitation program: the role of social work Abstract   PDF
D. Townsend, C. Accurso–Massana, C. Lechman, S. Duder, M. Chasen
Vol 23, No 6 (2016) Cancer referral and treatment activity 2010–2015: a population-based study from Vancouver Island Abstract   PDF   HTML
P. Savage, C. Holloway, G. Lindsay, K. Shubrook, C. Jones, M. Fung, K. Schaff, H. Anderson, K. Nystedt, J. Rauw
Vol 18, No 6 (2011) Cancer risk: are we well behaved? Abstract   PDF   HTML
A. G. Cramp, L. Fitzgeorge, H. Prapavessis
Vol 12, No 4 (2005) Cancer Stem Cells Revisited Details   PDF
Richard J Ablin, Brian L. Pipes
Vol 14, No 3 (2007) Cancer Symptom Control Trials: How May We Advance This Field? Details   PDF
Neil MacDonald
Aromatase Inhibitor Supplement, 2007 Cancer Therapy Disparity— Unequal Access to Breast Cancer Therapeutics and Drug Funding in Canada Details   PDF
Sunil Verma, Sandeep Sehdev, Anil Abraham Joy
Going Beyond Efficacy Cancer Treatment Related Bone Loss Abstract   PDF
Aliya Khan, Nazir Khan
Going Beyond Efficacy Cancer-Associated Thrombosis: Prevention and Treatment Details   PDF
Agnes Lee, Kelsey Brose
Vol 23 (2016): Use of Cannabinoids in Cancer Care Cannabis and cancer: towards a new understanding Abstract   PDF   HTML
M.A. Ware
Vol 26, No 4 (2019) Cannabis use in cancer: a survey of the current state at BC Cancer before recreational legalization in Canada Abstract   PDF   HTML
P. Hawley, M. Gobbo
Vol 27, No 1 (2020) CanPROS Scientific Conference 2019 Oral Abstracts Abstract   PDF   HTML
Various Authors
Vol 27, No 1 (2020) CanPROS Scientific Conference 2019 Poster Abstracts Abstract   PDF   HTML
Various Authors
Vol 18, No 2 (2011) Capecitabine or infusional 5-fluorouracil for gastroesophageal cancer: a cost–consequence analysis Abstract   PDF   HTML
A. M. Horgan, J. J. Knox, G. Liu, C. Sahi, P. A. Bradbury, N B. Leighl
Vol 17, No 1 (2010) Capecitabine-induced cardiotoxicity: case report and review of the literature Abstract   PDF
C. Ang, M. Kornbluth, M.P. Thirlwell, R.D. Rajan
Vol 24, No 3 (2017) Carcinoma ex pleomorphic adenoma: case report and options for systemic therapy Abstract   PDF   HTML
N. Chooback, Y. Shen, M. Jones, K. Kasaian, M. Martin, T. Ng, T. Thompson, M. Marra, J. Laskin, C. Ho
Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective Cardiac and cognitive effects of androgen deprivation therapy: are they real? Abstract   PDF
S. M.H. Alibhai, H. Z. Mohamedali
Vol 15, No 1 (2008) Cardiac Management During Adjuvant Trastuzumab Therapy: Recommendations of the Canadian Trastuzumab Working Group Abstract   PDF
John Mackey, Mark Clemons, Sunil Verma, Diego Delgado, Susan Dent, Alexander Paterson, Louise Provencher, Michael Sawyer, Marc Andre Cote
Vol 18, No 5 (2011) Caring for survivors of breast cancer: perspective of the primary care physician Abstract   PDF   HTML
S. L. Smith, E. S. Wai, C. Alexander, S. Singh-Carlson
Vol 20, No 2 (2013) Case report of very late gastric cancer recurrence Abstract   PDF   HTML
P. Blanchette, J.H. Lipton, D. Barth, H. Mackay
Vol 19, No 3 (2012) Casting stones and casting aspersions: let’s not lose sight of the main issues in the euthanasia debate Abstract   PDF   HTML
Jose Pereira
Vol 19, No 3 (2012) Caught in the middle: case study of a brachial (sentry) lymph node recurrence after resection and locoregional breast radiotherapy Abstract   PDF   HTML
G. Lee, M. Clemons, J. Cho, G.J. Czarnota, R. Dinniwell
Vol 22, No 5 (2015) Causes of death and subsequent treatment after initial radical or palliative therapy of stage III non-small-cell lung cancer Abstract   PDF   HTML
A.G. Robinson, K. Young, K. Balchin, A. Ashworth, T. Owen
Vol 17, No 4 (2010) Cetuximab in locally advanced head-and-neck cancer: defining the population Abstract   PDF
C. Ho
Vol 15, No 4 (2008) Cetuximab Treatment in a Patient with Metastatic Colorectal Cancer and Psoriasis Details   PDF
Bart Neyns, Vanessa Meert, Frederik Vandenbroucke
Vol 24, No 2 (2017) Challenges and insights in implementing coordinated care between oncology and primary care providers: a Canadian perspective Abstract   PDF   HTML
J.R. Tomasone, M. Vukmirovic, M.C. Brouwers, E. Grunfeld, R. Urquhart, M.A. O’Brien, M. Walker, F. Webster, M. Fitch
201 - 300 of 1728 Items << < 1 2 3 4 5 6 7 8 9 10 > >>